Relay Therapeutics, Inc.
RLAY- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001812364
In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Relay Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 132 | 1 | 131 | 0 |
| Shares | 91.8M | 6.60K | 111.0M | +19.2M (+20.9%) |
| Value | $2.89B | $208.0K | $3.41B | +$513.0M (+17.7%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Relay Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 549,055 | $16.9M | 0.30% |
| Putnam Investments LLC | 66,995 | $2.06M | 0.00% |
| Toronto Dominion Bank | 55,643 | $1.71M | 0.00% |
| Laurion Capital Management LP | 20,000 | $614.0K | 0.01% |
| Allspring Global Investments Holdings, LLC | 18,988 | $583.0K | 0.00% |
| AlphaCrest Capital Management LLC | 14,253 | $438.0K | 0.02% |
| Nomura Asset Management Co Ltd | 14,000 | $429.9K | 0.00% |
| Handelsbanken Fonder AB | 13,900 | $427.0K | 0.00% |
| Brown Advisory Inc | 12,914 | $397.0K | 0.00% |
| Allstate Corp | 8,600 | $264.0K | 0.01% |
| Teacher Retirement System of Texas | 7,956 | $244.0K | 0.00% |
| EDBI Pte Ltd | 7,484 | $230.0K | 0.12% |
| XTX Topco Ltd | 7,174 | $220.0K | 0.12% |
| Vontobel Holding Ltd. | 6,580 | $202.0K | 0.00% |
| Ensign Peak Advisors, Inc | 4,660 | $143.0K | 0.00% |
| Parallel Advisors, LLC | 71 | $2.00K | 0.00% |
| Covestor Ltd | 19 | $1.00K | 0.00% |
| Captrust Financial Advisors | 10 | $0 | 0.00% |
Sold out (18)
Institutions that held Relay Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Two Sigma Investments, LP | 191,891 | $6.05M |
| Voloridge Investment Management, LLC | 70,253 | $2.21M |
| Alpine Global Management, LLC | 59,374 | $1.87M |
| First Light Asset Management, LLC | 51,848 | $1.64M |
| Jane Street Group, LLC | 19,364 | $611.0K |
| Janus Henderson Group PLC | 17,004 | $534.0K |
| Winton Group Ltd | 13,964 | $440.0K |
| Dynamic Technology Lab Private Ltd | 11,340 | $358.0K |
| Point72 Hong Kong Ltd | 11,267 | $355.0K |
| Blueshift Asset Management, LLC | 9,836 | $310.0K |
| Virtu Financial LLC | 7,512 | $237.0K |
| Gotham Asset Management, LLC | 7,394 | $233.0K |
| Aigen Investment Management, LP | 7,328 | $231.0K |
| Susquehanna Fundamental Investments, LLC | 7,300 | $230.0K |
| Penserra Capital Management LLC | 2,115 | $66.0K |
| Signaturefd, LLC | 495 | $16.0K |
| TCI Wealth Advisors, Inc. | 146 | $5.00K |
| Jacobi Capital Management LLC | 94 | $3.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Relay Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 6,600 | $208.0K |